Additionally, hyperactivation of pre-existing T cells could contribute to short- and long-term disease severity via inflammation and autoimmunity, as increased production of IFN- by CD4+ and CD8+ T cells has been observed in severe COVID-19 patients (45). This evidence concerns the gene IFNA1 and COVID-19.